On Friday, Replimune Group Inc (NASDAQ: REPL) was 3.14% up from the session before settling in for the closing price of $9.87. A 52-week range for REPL has been $2.68 – $14.80.
During the last 5-year period, the sales drop of Healthcare Sector giant was -14.85%. When this article was written, the company’s average yearly earnings per share was at -4.40%. With a float of $71.04 million, this company’s outstanding shares have now reached $78.40 million.
Replimune Group Inc (REPL) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Replimune Group Inc stocks. The insider ownership of Replimune Group Inc is 9.44%, while institutional ownership is 100.33%. The most recent insider transaction that took place on Dec 09 ’25, was worth 32,958. In this transaction Director of this company sold 3,169 shares at a rate of $10.40, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 09 ’25, when Company’s Director proposed sale 3,164 for $10.38, making the entire transaction worth $32,842.
Replimune Group Inc (REPL) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.79 earnings per share (EPS) during the time that was less than consensus figure (set at -0.72) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.11% during the next five years compared to -14.85% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
You can see what Replimune Group Inc (REPL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.61, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.12 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Looking closely at Replimune Group Inc (NASDAQ: REPL), its last 5-days average volume was 1.65 million, which is a drop from its year-to-date volume of 4.21 million. As of the previous 9 days, the stock’s Stochastic %D was 31.76%.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 86.89%, which indicates a significant increase from 48.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.60 in the past 14 days, which was higher than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.35, while its 200-day Moving Average is $8.13. However, in the short run, Replimune Group Inc’s stock first resistance to watch stands at $10.44. Second resistance stands at $10.69. The third major resistance level sits at $11.10. If the price goes on to break the first support level at $9.78, it is likely to go to the next support level at $9.37. Should the price break the second support level, the third support level stands at $9.12.
Replimune Group Inc (NASDAQ: REPL) Key Stats
There are 78,443K outstanding shares of the company, which has a market capitalization of 798.55 million. As of now, sales total 0 K while income totals -247,300 K. Its latest quarter income was 0 K while its last quarter net income were -83,100 K.
